Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
GOLDMAN SACHS GROUP INC LGND Ligand Pharmaceuticals Inc 13G 6.8% 2y
Capital International Investors ITT Itt Inc. 13G/A 11.9% 2y
GOLDMAN SACHS GROUP INC SLN Silence Therapeutics plc 13G/A 2.2% 2y
Capital World Investors ARES Ares Management Corp 13G/A 6% 2y
Invesco Ltd. BAB Invesco Exchange-Traded Fund Trust II 13G/A 17.1% 2y
Odyssey Health, Inc. OGEN Oragenics Inc 13D 16.6% 2y
TOCQUEVILLE ASSET MANAGEMENT L.P. CSBR Champions Oncology, Inc. 13G 5% 2y
Cantor Fitzgerald Securities PARA Parabolic Technologies, Inc. 13G 8.8% 2y
Hertford Advisors Ltd. DRK DarkHorse Technologies Inc. 13G 9.99% 2y
Michael Bigger BDRX Biodexa Pharmaceuticals Plc 13G 9.9% 2y
TOCQUEVILLE ASSET MANAGEMENT L.P. NCSM NCS Multistage Holdings, Inc. 13G 5.5% 2y
Bulldog Investors, LLP CCIF Carlyle Credit Income Fund 13D/A 1.2% 2y
Saudi Research and Media Group ANGH Anghami Inc 13G 6.9% 2y
Cantor Fitzgerald Securities AMOD Alpha Modus Holdings, Inc. 13G 5.5% 2y
K2 PRINCIPAL FUND, L.P. ILLMF illumin Holdings Inc. 13G/A 3.26% 2y
K2 PRINCIPAL FUND, L.P. SJT San Juan Basin Royalty Trust 13G/A 4.75% 2y
Gareth Sheridan NTRB NutriBand Inc. 13G 19.88% 2y
Arthur Richards Rule IV SII Sprott Inc. 13G/A 10.5% 2y
ARISON MICKY MEIR CCL Carnival Corp Ltd. 13D/A 7.7% 2y
Zeno Investment Master Fund MLKMF Waldencast plc 13D/A 18.8% 2y
LSP 6 Holding C.V. NKTX Nkarta, Inc. 13D/A 5.8% 2y
Velan Capital Investment Management LP JSPR Jasper Therapeutics, Inc. 13D/A 9.8% 2y
GAMCO INVESTORS, INC. ET AL FARM FARMER BROTHERS CO 13D/A 3.7% 2y
GAMCO INVESTORS, INC. ET AL CYT Cyteir Therapeutics, Inc. Common Stock 13D/A 3.66% 2y
Liang Meng HOLI Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island) 13D/A 13.7% 2y
Saba Capital Management, L.P. ADX Adams Diversified Equity Fund, Inc. 13D/A 6.55% 2y
Eric R. Colson APAM Artisan Partners Asset Management Inc. 13D/A 12.3% 2y
Walgreens Boots Alliance, Inc. COR Cencora, Inc. 13D/A 13.2% 2y
Mill Road Capital III, L.P. ALTG Alta Equipment Group Inc. 13D/A 9.4% 2y
K2 PRINCIPAL FUND, L.P. HHLA HH&L Acquisition Co. 13G 7.08% 2y
Chad Richison PAYC Paycom Software, Inc. 13D/A 11.6% 2y
Monte M. Brem STEP StepStone Group Inc. 13D/A 49.8% 2y
BRC Group Holdings, Inc. ALTG Alta Equipment Group Inc. 13D/A 0.7% 2y
Troy Dias POL Polished.com Inc. 13G 11.85% 2y
Alpha Wave Global, LP ANRO Alto Neuroscience, Inc. 13G 13.8% 2y
Lind Global Fund II LP CING Cingulate Inc. 13G 9.9% 2y
Peter J. Werth CING Cingulate Inc. 13D/A 19.99% 2y
COWEN AND COMPANY, LLC TCOA Zalatoris Acquisition Corp. 13G 3.93% 2y
Chong Chan Teo TGL Treasure Global Inc 13D 5.7% 2y
SPRING CREEK CAPITAL LLC USAR USA Rare Earth, Inc. 13G 5.45% 2y
Tencent Holdings Limited AS Amer Sports, Inc. 13D 6.5% 2y
Dodge & Cox JCI Johnson Controls International plc 13G/A 11% 2y
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ DNB Dun & Bradstreet Holdings, Inc. 13G/A 10.6% 2y
BlackRock Inc. SSTI Soundthinking, Inc. 13G/A 4.9% 2y
EARNEST PARTNERS LLC FCFS FirstCash Holdings, Inc. 13G/A 5.1% 2y
MORGAN STANLEY NCZ Virtus Convertible & Income Fund II 13G/A 10.1% 2y
Bank of New York Mellon Corp LRGE Legg Mason ETF Investment Trust 13G/A 18.23% 2y
CITY OF LONDON INVESTMENT MANAGEMENT CO LTD IAE Voya Asia Pacific High Dividend Equity Income Fund 13G/A 32.5% 2y
Stonepine Capital Management, LLC KPRX Kiora Pharmaceuticals Inc 13G 9.99% 2y
Bank of New York Mellon Corp BUYZ Franklin Templeton ETF Trust 13G/A 5.5% 2y